Inventor
DEGNAN ANDREW P
US20 patents
⚠️ This page may combine multiple inventors who share the name “DEGNAN ANDREW P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
19 patentsUS7569578B2Aug 4, 2009
Heterocyclic anti-migraine agents
BRISTOL MYERS SQUIBB CO14 citations84
US7842808B2Nov 30, 2010
Anti-migraine spirocycles
BRISTOL MYERS SQUIBB CO13 citations83
US7772244B2Aug 10, 2010
Therapeutic agents for the treatment of migraine
BRISTOL MYERS SQUIBB CO12 citations83
US7314883B2Jan 1, 2008
Anti-migraine treatments
BRISTOL MYERS SQUIBB CO12 citations83
US7220862B2May 22, 2007
Calcitonin gene related peptide receptor antagonists
BRISTOL MYERS SQUIBB CO11 citations81
US9695176B2Jul 4, 2017
Substituted imidazo[1,5-a]pyrazines as CGRP receptor antagonists
BRISTOL MYERS SQUIBB CO6 citations72
US9725449B2Aug 8, 2017
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO2 citations71
US11548870B2Jan 10, 2023
Compounds useful as inhibitors of helios protein
BRISTOL MYERS SQUIBB CO1 citations61
US8026257B2Sep 27, 2011
Substituted heterocyclic ethers and their use in CNS disorders
BRISTOL MYERS SQUIBB CO4 citations61
USRE49735ENov 28, 2023
Oxazolidinones as modulators of MGLUR5
BRISTOL MYERS SQUIBB CO0 citations60
US11166959B2Nov 9, 2021
Isofuranone compounds useful as HPK1 inhibitors
BRISTOL MYERS SQUIBB CO1 citations59
US12486267B2Dec 2, 2025
Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis
BRISTOL MYERS SQUIBB CO0 citations51
US9751879B2Sep 5, 2017
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO1 citations51
US9688669B2Jun 27, 2017
Oxazolidinones as modulators of mGluR5
BRISTOL MYERS SQUIBB CO1 citations49
US12570671B2Mar 10, 2026
Substituted oxoisoindoline compounds for the treatment of cancer
BRISTOL MYERS SQUIBB CO0 citations48
US7179926B2Feb 20, 2007
Aryloxyalkylamine NK-1/SSRI inhibitors
BRISTOL MYERS SQUIBB CO0 citations48
US10174024B2Jan 8, 2019
5H-pyrido[3,2-B]indole compounds as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations40
US7632861B2Dec 15, 2009
Substituted heterocyclic ethers and their use in CNS disorders
BRISTOL MYERS SQUIBB CO0 citations40
US8383821B2Feb 26, 2013
NK-1 and serotonin transporter inhibitors
BRISTOL MYERS SQUIBB CO0 citations39